Capital Analysts, LLC: PDEC position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Analysts, LLC on PDEC, newest first. How the timeline and the estimate are built.
Capital Analysts, LLC held 82,108 PDEC shares at 2026-09-30 per its 13F-HR filed 2026-11-13.
the latest 13F is the newest step
- period ended2026-09-3013F 82,108 sharesChange vs previous 13F -2,829 shares
0.08% of the 13F portfolio, value $3,868,190.
13F-HR 0001624758-26-000047 filed by Capital Analysts, LLC
Accepted , ingested - period ended2026-06-3013F/A 84,937 sharesChange vs previous 13F 0 shares
0.09% of the 13F portfolio, value $3,897,759.
13F-HR/A 0001624758-26-000016 filed by Capital Analysts, LLC
Accepted , ingested - period ended2026-03-3113F/A 84,937 sharesChange vs previous 13F 0 shares
0.09% of the 13F portfolio, value $3,609,823.
13F-HR/A 0001624758-26-000018 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-12-3113F/A 84,937 sharesChange vs previous 13F -40,121 shares
0.1% of the 13F portfolio, value $3,684,567.
13F-HR/A 0001624758-26-000020 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-09-3013F/A 125,058 sharesChange vs previous 13F 0 shares
0.15% of the 13F portfolio, value $5,254,937.
13F-HR/A 0001624758-26-000022 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-06-3013F/A 125,058 sharesChange vs previous 13F 0 shares
0.17% of the 13F portfolio, value $5,003,571.
13F-HR/A 0001624758-26-000024 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-03-3113F/A 125,058 sharesChange vs previous 13F 0 shares
0.18% of the 13F portfolio, value $4,702,181.
13F-HR/A 0001624758-26-000026 filed by Capital Analysts, LLC
Accepted , ingested - period ended2024-12-3113F/A 125,058 sharesChange vs previous 13F not available
0.19% of the 13F portfolio, value $4,804,729.
13F-HR/A 0001624758-26-000028 filed by Capital Analysts, LLC
Accepted , ingested